H2Ocean Highlights the Potential of Natural Sea Salt Based Oral Care at CPRIT Innovations VII Cancer Conference 2026

H2Ocean engages with cancer researchers, professionals, and industry innovators to explore supportive cancer care, survivorship, and quality of life solutions.

STUART, FL, UNITED STATES, October 27, 2026 /EINPresswire.com/ -- H2Ocean LLC, an innovator in natural sea salt based healthcare solutions, proudly participated in CPRIT Innovations VII: The Cancer Prevention and Research Conference, held October 5–7, 2026, at the Moody Gardens Hotel, Spa & Convention Center in Galveston, Texas.

Organized by the Cancer Prevention and Research Institute of Texas (CPRIT), the conference brought together more than 600 attendees, including cancer researchers, oncologists, clinicians, biotechnology innovators, prevention specialists, patient advocates, and industry leaders. With approximately 60 speakers and more than 250 scientific poster presentations, the event provided an exceptional platform for knowledge exchange, scientific discovery, and collaborative efforts to improve cancer prevention, treatment, and survivorship. Building on its participation in the 2024 conference, H2Ocean returned in 2026 with a continued commitment to advancing conversations about natural, science-driven supportive healthcare solutions.

H2Ocean Engages Cancer Research and Healthcare Communities: Representing H2Ocean at the conference were Eddie Kolos, Founder and Chief Executive Officer, and Dr. Rajiv Saini, Chief Scientific Officer. Throughout the event, both leaders actively engaged with CPRIT leadership, cancer researchers, oncology professionals, healthcare providers, and visitors to the company's exhibition booth. H2Ocean's booth offered attendees an opportunity to explore its innovative sea salt based formulations, learn about their potential applications in supportive oral care, and receive product samples and educational information. A particularly encouraging aspect of the conference was the interest expressed by healthcare professionals and researchers in how mineral rich sea salt based formulations could contribute to oral comfort, oral hygiene, and overall quality of life among individuals undergoing or recovering from cancer treatment. These discussions highlighted the importance of exploring practical, patient centered approaches that complement established medical care, particularly for individuals experiencing oral complications associated with chemotherapy, radiation therapy, and other cancer treatments.

CPRIT Innovations VII showcased significant scientific progress across the cancer care continuum. The conference featured discussions on emerging cancer therapies, early detection and screening, translational research, biotechnology commercialization, clinical trials, and expanding access to preventive services. Major highlights included developments in artificial intelligence and its expanding role in science, opportunities to translate laboratory discoveries into clinical innovations, community driven cancer prevention initiatives, and strategies to strengthen research collaborations. The conference also marked the unveiling of the Texas Cervical Cancer Elimination Plan 2027–2032, a statewide initiative designed to accelerate progress through prevention, screening, and coordinated healthcare efforts. Another important dimension was the emphasis on patient experiences and the need to consider long term outcomes, survivorship, and quality of life alongside advances in cancer treatment. Together, these discussions demonstrated the value of bringing scientists, healthcare professionals, industry innovators, and patient advocates together to address the complex challenges of cancer care.

The conference also celebrated excellence through the Texans Conquer Cancer Awards. The conference opened with a special awards ceremony recognizing outstanding contributions to cancer research, prevention, innovation, and clinical care. The 2026 Texans Conquer Cancer Awards honored four distinguished researchers and healthcare leaders:

Dr. Zhiqiang An, UTHealth Houston for Innovation
Dr. Keith Argenbright, UT Southwestern Medical Center for Population Health
Dr. Abbey Berenson, University of Texas Medical Branch for Clinical Care
Dr. Michael D. Taylor, Baylor College of Medicine for High Impact Research

CPRIT also presented its Champion Awards to Annette Leslie, founder of the Carson Leslie Foundation, and Wayne Roberts, former Chief Executive Officer of CPRIT, recognizing their exceptional dedication to advancing cancer research and improving the lives of Texans. These recognitions celebrated the extraordinary contributions of individuals working to transform cancer outcomes through scientific excellence, leadership, and community engagement.

Exploring the Potential of Natural Sea Salt in Supportive Cancer Care: For H2Ocean, a central takeaway from the conference was the growing importance of supportive care solutions that address the everyday challenges experienced by cancer patients and survivors. Cancer therapies can affect oral health, contributing to chemo mouth conditions such as oral mucositis, dry mouth, oral discomfort, and difficulties maintaining routine oral hygiene. These complications may significantly affect nutrition, comfort, and overall quality of life. H2Ocean's sea salt based oral care formulations, developed with a focus on gentle cleansing and oral hygiene, represent an area of interest for supportive oral care research.

The company believes that exploring mineral rich sea salt, in combination with carefully selected oral care ingredients, may create opportunities for developing practical approaches to support oral health and patient comfort during cancer treatment and recovery. While further clinical research is necessary to establish specific benefits in oncology populations, H2Ocean remains committed to encouraging scientific evaluation, interdisciplinary collaboration, and evidence based approaches to supportive care. Importantly, these solutions are intended to complement, not replace, established cancer prevention strategies, oncologic treatment, or professional medical guidance. Eddie Kolos, Founder and Chief Executive Officer, H2Ocean, shared, "It was truly inspiring to engage with CPRIT leadership and the cancer research community. For more than two decades, we have believed in the remarkable potential of natural sea salt in healthcare. Seeing growing scientific interest in its possible applications for cancer survivorship and supportive care strengthens our commitment to innovation, research, and developing solutions that can make a meaningful difference in people's lives."

Beyond the scientific sessions, CPRIT Innovations VII provided H2Ocean with valuable opportunities to establish and strengthen relationships with researchers, clinical professionals, academic institutions, biotechnology organizations, and healthcare leaders. The company's leadership team welcomed conversations about potential collaborative research, clinical evaluation, educational initiatives, and opportunities to better understand the needs of patients and survivors. The enthusiasm and engagement of booth visitors further reinforced H2Ocean's commitment to connecting natural product innovation with meaningful scientific investigation.

One of the most memorable highlights of H2Ocean's participation was the visit of Kristen Doyle, Chief Executive Officer of CPRIT, and Heidi McConnell, Deputy Executive Officer and Chief Operating Officer, to the company's exhibition booth. Both leaders spent considerable time engaging with Eddie Kolos and Dr. Rajiv Saini, gaining insights into the science behind mineral rich sea salt formulations and discussing their potential applications in cancer survivorship, supportive oral care, and improving patients' quality of life. The discussions explored how natural sea salt based innovations could open new avenues for scientific research, particularly in addressing oral health challenges associated with cancer therapies. Their thoughtful engagement provided an encouraging opportunity to exchange ideas about the future of patient-centered supportive healthcare. Dr. Rajiv Saini, Chief Scientific Officer, H2Ocean, emphasized, "Cancer survivorship is not only about extending life but also about improving its quality. Oral health plays a critical role in patient comfort, nutrition, and overall well-being, particularly during and after cancer therapy. Our discussions at CPRIT reinforced the importance of scientifically evaluating natural sea salt-based formulations as potential supportive oral care solutions. We see exciting opportunities for collaborative research to better understand their role in improving the everyday experiences of cancer patients and survivors."

The company also congratulates the award recipients and recognizes the dedicated professionals whose ongoing work continues to advance cancer research, prevention, treatment, and survivorship. H2Ocean looks forward to building on the relationships established during CPRIT Innovations VII and contributing to future discussions about supportive healthcare innovation, oral health, and improving quality of life for cancer patients and survivors. H2Ocean is a healthcare product innovation company specializing in natural sea salt based formulations for oral care, skin care, hair care, first aid, and aftercare applications. With a commitment to product innovation, scientific collaboration, and consumer well-being, H2Ocean continues to explore the potential of mineral-rich sea salt and complementary ingredients in supporting daily health, hygiene, and personal care.

Rajiv Saini
H2Ocean LLC
+1 772-219-8183
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X

H2Ocean Participation at CPRIT Conference 2026